Main Street Research LLC Has $41.51 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Main Street Research LLC raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 79,531 shares of the medical equipment provider's stock after purchasing an additional 1,482 shares during the quarter. Intuitive Surgical comprises 2.6% of Main Street Research LLC's portfolio, making the stock its 15th largest holding. Main Street Research LLC's holdings in Intuitive Surgical were worth $41,512,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in ISRG. Massachusetts Financial Services Co. MA bought a new position in Intuitive Surgical during the 3rd quarter valued at $558,807,000. Proficio Capital Partners LLC boosted its stake in shares of Intuitive Surgical by 89,098.8% during the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider's stock worth $495,845,000 after acquiring an additional 948,902 shares in the last quarter. FMR LLC boosted its stake in shares of Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock worth $5,389,765,000 after acquiring an additional 838,793 shares in the last quarter. Raymond James Financial Inc. bought a new stake in shares of Intuitive Surgical during the 4th quarter worth $313,769,000. Finally, Wilmington Savings Fund Society FSB boosted its stake in shares of Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider's stock worth $272,980,000 after acquiring an additional 552,058 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Remove Ads

Insider Buying and Selling

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the firm's stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the firm's stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 22,209 shares of company stock worth $11,928,127. Corporate insiders own 0.90% of the company's stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG traded up $3.58 during midday trading on Wednesday, hitting $497.30. 2,557,102 shares of the stock were exchanged, compared to its average volume of 1,425,013. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The business's fifty day simple moving average is $569.42 and its two-hundred day simple moving average is $531.60. The company has a market capitalization of $177.13 billion, a PE ratio of 77.58, a P/E/G ratio of 5.85 and a beta of 1.43.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on ISRG shares. Raymond James raised their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. Royal Bank of Canada raised their price objective on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Piper Sandler reissued an "overweight" rating and set a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Morgan Stanley raised Intuitive Surgical from an "equal weight" rating to an "overweight" rating and raised their price objective for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Finally, Citigroup increased their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.